Literature DB >> 6751333

Hypoxic cell radiosensitizers as potential adjuvants to conventional chemotherapy for the treatment of cancer.

B C Millar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6751333     DOI: 10.1016/0006-2952(82)90051-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  12 in total

Review 1.  Clinical pharmacology of 5-fluorouracil.

Authors:  R B Diasio; B E Harris
Journal:  Clin Pharmacokinet       Date:  1989-04       Impact factor: 6.447

2.  In vitro potentiation of BCNU activity in rat brain tumour cells pretreated with misonidazole.

Authors:  D W Siemann; K Wolf; S Morrissey; K T Wheeler
Journal:  Br J Cancer       Date:  1984-06       Impact factor: 7.640

3.  Effects on intermediary metabolism in mouse tissues by Ro-03-8799.

Authors:  P Tamulevicius; G Luscher; C Streffer
Journal:  Br J Cancer       Date:  1987-09       Impact factor: 7.640

4.  Misonidazole reduces blood flow in two experimental murine tumours.

Authors:  J C Murray; V S Randhawa
Journal:  Br J Cancer       Date:  1988-08       Impact factor: 7.640

5.  Chemopotentiation in vivo: no loss of sensitization with fractionation.

Authors:  S A Hill; D W Siemann
Journal:  Br J Cancer       Date:  1984-10       Impact factor: 7.640

6.  Factors influencing the chemosensitization of melphalan by misonidazole.

Authors:  V S Randhawa; F A Stewart; J Denekamp; M R Stratford
Journal:  Br J Cancer       Date:  1985-02       Impact factor: 7.640

7.  Effect of misonidazole pretreatment on nitrogen mustard-induced DNA cross-linking in mouse tissues in vivo.

Authors:  D Murray; R E Meyn
Journal:  Br J Cancer       Date:  1984-12       Impact factor: 7.640

8.  Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.

Authors:  F Y Lee; P Workman
Journal:  Br J Cancer       Date:  1983-05       Impact factor: 7.640

9.  The effects of melphalan and misonidazole on the vasculature of a murine sarcoma.

Authors:  J C Murray; V Randhawa; J Denekamp
Journal:  Br J Cancer       Date:  1987-03       Impact factor: 7.640

10.  Enhancement of the DNA cross-linking activity of melphalan by misonidazole in vivo.

Authors:  D Murray; R E Meyn
Journal:  Br J Cancer       Date:  1983-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.